TT&A, SAM act on Quadria Capital acquiring minority stake in Aragen Life Sciences for $100 million

TT&A and Shardul Amarchand Mangaldas (SAM) acted on Quadria Capital's acquisition of a minority shareholding in Aragen Life Sciences Limited through a combination of primary and secondary investment for $100 million.

TT&A advised Quadria Capital on this transaction.

The transaction team consisted of Gautam Saha (Partner), Amrita Patnaik (Partner), Ambika Sahai (Managing Associate) and Aditi Somani (Senior Associate).

Garvita Mehrotra (Managing Associate) also assisted on this deal.

Shardul Amarachand Mangaldas & Co advised Aragen Life Sciences on this transaction.

This funding will support Aragen’s strategic expansion of its capabilities and infrastructure, enabling Aragen to meet the growing demand for outsourcing services from innovators in the US and Europe. With this investment, Quadria joins Goldman Sachs as the second strategic investor in Aragen and this partnership solidifies Aragen’s reputation for delivering high-quality “concept to clinic” and “concept to commercial” services to its global customer base comprising all sectors of health – Human, Animal and Plant.

Aragen Life Sciences is a leading research and development partner to the global biotech industry, accelerating innovation and product development from concept to the clinic.

They offer a comprehensive suite of services across the drug development continuum, specializing in early-stage discovery and development of new molecular entities (NMEs). With a focus on both small and large molecules, Aragen empowers clients with cutting-edge technology platforms and a talented team to translate scientific investigations into potential therapies

Quadria Capital is a leading healthcare-focused private equity firm that specializes in growth capital investments in small and mid-market companies across South and Southeast Asia.

Founded in 2012, Quadria Capital aims to improve access to quality healthcare in the region by supporting promising companies that are developing innovative solutions and expanding healthcare access in underserved communities.

f you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.